Cost-effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma.
CONCLUSION: Taking into consideration 16 patients for TTS and 22 patients for TS pathways, the TTS sequence provided a dominant strategy in comparison to TS. Further evidence is desirable to confirm these results.
PMID: 29231047 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Cancer & Oncology | Carcinoma | General Medicine | Hepatocellular Carcinoma | Italy Health | Liver Cancer